vs
INSEEGO CORP.（INSG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是INSEEGO CORP.的1.6倍（$75.5M vs $48.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 0.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $11.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.6%）
Inseego Corp是全球领先的5G及物联网解决方案提供商，主打移动热点、边缘计算设备及云端设备管理平台产品，客户覆盖全球范围内的电信运营商、企业及公共部门。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
INSG vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$48.4M
营收增速更快
PBYI
高出27.1%
0.6%
自由现金流更多
PBYI
多$2.8M
$11.6M
两年增速更快
PBYI
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.4M | $75.5M |
| 净利润 | $469.0K | — |
| 毛利率 | 42.2% | 69.3% |
| 营业利润率 | 2.7% | 22.7% |
| 净利率 | 1.0% | — |
| 营收同比 | 0.6% | 27.7% |
| 净利润同比 | 182.9% | — |
| 每股收益（稀释后） | $-0.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSGPBYI
| Q4 25 | $48.4M | $75.5M | ||
| Q3 25 | $45.9M | $54.5M | ||
| Q2 25 | $40.2M | $52.4M | ||
| Q1 25 | $31.7M | $46.0M | ||
| Q4 24 | $48.1M | $59.1M | ||
| Q3 24 | $54.0M | $80.5M | ||
| Q2 24 | $51.6M | $47.1M | ||
| Q1 24 | $37.5M | $43.8M |
净利润INSGPBYI
| Q4 25 | $469.0K | — | ||
| Q3 25 | $1.4M | $8.8M | ||
| Q2 25 | $507.0K | $5.9M | ||
| Q1 25 | $-1.6M | $3.0M | ||
| Q4 24 | $-566.0K | — | ||
| Q3 24 | $9.0M | $20.3M | ||
| Q2 24 | $624.0K | $-4.5M | ||
| Q1 24 | $-4.5M | $-4.8M |
毛利率INSGPBYI
| Q4 25 | 42.2% | 69.3% | ||
| Q3 25 | 41.6% | 77.7% | ||
| Q2 25 | 41.1% | 76.5% | ||
| Q1 25 | 47.3% | 77.1% | ||
| Q4 24 | 37.3% | 76.4% | ||
| Q3 24 | 34.8% | 63.9% | ||
| Q2 24 | 36.4% | 77.4% | ||
| Q1 24 | 35.3% | 75.5% |
营业利润率INSGPBYI
| Q4 25 | 2.7% | 22.7% | ||
| Q3 25 | 4.7% | 17.6% | ||
| Q2 25 | 3.2% | 12.7% | ||
| Q1 25 | -1.3% | 8.7% | ||
| Q4 24 | 3.7% | 22.6% | ||
| Q3 24 | 1.9% | 27.4% | ||
| Q2 24 | 3.6% | -4.6% | ||
| Q1 24 | -7.9% | -5.3% |
净利率INSGPBYI
| Q4 25 | 1.0% | — | ||
| Q3 25 | 3.1% | 16.2% | ||
| Q2 25 | 1.3% | 11.2% | ||
| Q1 25 | -5.0% | 6.5% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 16.6% | 25.2% | ||
| Q2 24 | 1.2% | -9.6% | ||
| Q1 24 | -11.9% | -11.0% |
每股收益（稀释后）INSGPBYI
| Q4 25 | $-0.02 | $0.26 | ||
| Q3 25 | $0.03 | $0.17 | ||
| Q2 25 | $-0.03 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $0.62 | $0.40 | ||
| Q3 24 | $-0.06 | $0.41 | ||
| Q2 24 | $-0.02 | $-0.09 | ||
| Q1 24 | $-0.44 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.9M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $-4.0M | $130.3M |
| 总资产 | $93.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资INSGPBYI
| Q4 25 | $24.9M | $97.5M | ||
| Q3 25 | $14.6M | $94.4M | ||
| Q2 25 | $13.2M | $96.0M | ||
| Q1 25 | $35.1M | $93.2M | ||
| Q4 24 | $39.6M | $101.0M | ||
| Q3 24 | $12.0M | $96.7M | ||
| Q2 24 | $49.0M | $96.8M | ||
| Q1 24 | $12.3M | $107.2M |
总债务INSGPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益INSGPBYI
| Q4 25 | $-4.0M | $130.3M | ||
| Q3 25 | $-7.7M | $115.3M | ||
| Q2 25 | $-10.5M | $104.7M | ||
| Q1 25 | $-13.0M | $97.1M | ||
| Q4 24 | $-12.9M | $92.1M | ||
| Q3 24 | $-85.1M | $71.1M | ||
| Q2 24 | $-101.8M | $48.5M | ||
| Q1 24 | $-105.6M | $51.0M |
总资产INSGPBYI
| Q4 25 | $93.8M | $216.3M | ||
| Q3 25 | $85.8M | $202.9M | ||
| Q2 25 | $83.1M | $194.9M | ||
| Q1 25 | $93.0M | $196.2M | ||
| Q4 24 | $100.0M | $213.3M | ||
| Q3 24 | $113.4M | $220.7M | ||
| Q2 24 | $149.6M | $205.0M | ||
| Q1 24 | $122.1M | $214.1M |
负债/权益比INSGPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $14.4M |
| 自由现金流率自由现金流/营收 | 24.0% | 19.1% |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | 25.50× | — |
| 过去12个月自由现金流最近4个季度 | $6.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流INSGPBYI
| Q4 25 | $12.0M | $14.4M | ||
| Q3 25 | $3.2M | $9.7M | ||
| Q2 25 | $-4.5M | $14.1M | ||
| Q1 25 | $-3.5M | $3.6M | ||
| Q4 24 | $-14.2M | $15.6M | ||
| Q3 24 | $14.8M | $11.0M | ||
| Q2 24 | $27.6M | $1.0M | ||
| Q1 24 | $5.2M | $11.2M |
自由现金流INSGPBYI
| Q4 25 | $11.6M | $14.4M | ||
| Q3 25 | $3.1M | $9.7M | ||
| Q2 25 | $-4.7M | $14.1M | ||
| Q1 25 | $-3.5M | $3.6M | ||
| Q4 24 | $-14.3M | $15.6M | ||
| Q3 24 | $14.8M | $11.0M | ||
| Q2 24 | $27.6M | $1.0M | ||
| Q1 24 | — | — |
自由现金流率INSGPBYI
| Q4 25 | 24.0% | 19.1% | ||
| Q3 25 | 6.7% | 17.7% | ||
| Q2 25 | -11.6% | 26.8% | ||
| Q1 25 | -11.0% | 7.7% | ||
| Q4 24 | -29.7% | 26.4% | ||
| Q3 24 | 27.4% | 13.7% | ||
| Q2 24 | 53.5% | 2.1% | ||
| Q1 24 | — | — |
资本支出强度INSGPBYI
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率INSGPBYI
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | 1.10× | ||
| Q2 25 | -8.81× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | 0.54× | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
